Determination of fibrinolysis inhibitor activity in pregnancy. Preparation of plasminogen
Fantoni, A.; Cassolini, G.M.; Gobbi, F.; Chiappa, A.; Turinetti, C.; Julitta, R.
Archivio Per le Scienze Mediche 138(2): 199-200
1981
ISSN/ISBN: 0004-0312 PMID: 7247714 Document Number: 176052
An attempt was made to find a practical method for the determination of fibrinolysis inhibitors in pregnancy . The 1st problem examined was that of the preparation of a concentrated solution of plasminogen.
Document emailed within 1 workday
Related Documents
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422
Nicoloso, G.; Hauert, J.; Kruithof, E.K.; Van Melle, G.; Bachmann, F. 1988: Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system Thrombosis and Haemostasis 59(2): 299-303
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Humphries, S.E.; Lane, A.; Dawson, S.; Green, F.R. 1992: The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VIi and plasminogen activator inhibitor-1 Archives of Pathology and Laboratory Medicine 116(12): 1322-1329
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Munkvad, S. 1993: Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways Danish Medical Bulletin 40(4): 383-408
Sprengers, E.D.; Akkerman, J.W.; Jansen, B.G. 1986: Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood Thrombosis and Haemostasis 55(3): 325-329
Gray, R.P.; Mohamed-Ali, V.; Patterson, D.L.; Yudkin, J.S. 1995: Determinants of plasminogen activator inhibitor-1 activity in survivors of myocardial infarction Thrombosis and Haemostasis 73(2): 261-267
Jovan P. Antovic 2003: Thrombin Activatable Fibrinolysis Inhibitor (TAFI) A Link between Coagulationand Fibrinolysis Clinical Laboratory 49(9-10): 475-486
Von Tempelhoff, G.F.; Heilmann, L.; Dietrich, M.; Schneider, D.; Niemann, F.; Hommel, G. 1997: Plasmatic plasminogen activator inhibitor activity in patients with primary breast cancer Thrombosis and Haemostasis 77(3): 606-608
Primrose, J.N.; Davies, J.A.; Prentice, C.R.; Hughes, R.; Johnston, D. 1992: Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity Thrombosis and Haemostasis 68(4): 396-399
Kruithof, E.K.; Gudinchet, A.; Bachmann, F. 1988: Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states Thrombosis and Haemostasis 59(1): 7-12
Jastrzebska, M.; Przybycień, K.; Chelstowski, K.; Torbus-Lisiecka, B.; Kornacewicz-Jach, Z.; Naruszewicz, M. 1999: Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography Nutrition Metabolism and Cardiovascular Diseases: Nmcd 9(1): 33-40
Levin, G.I. 1975: Thromboelastographic method of determination of plasminogen proactivator, antiactivator, and antiplasmin activity Laboratornoe Delo 11: 650-651
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109